In vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imaging

IntroductionTransplantation of human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) is a promising treatment for heart failure. Information on long-term cell engraftment after transplantation is clinically important. However, clinically applicable evaluation methods have not yet bee...

Full description

Bibliographic Details
Main Authors: Yukihiro Saito, Naoko Nose, Toshihiro Iida, Kaoru Akazawa, Takayuki Kanno, Yuki Fujimoto, Takanori Sasaki, Masaru Akehi, Takahiro Higuchi, Satoshi Akagi, Masashi Yoshida, Toru Miyoshi, Hiroshi Ito, Kazufumi Nakamura
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1261330/full
_version_ 1797690631472021504
author Yukihiro Saito
Naoko Nose
Toshihiro Iida
Kaoru Akazawa
Takayuki Kanno
Yuki Fujimoto
Takanori Sasaki
Masaru Akehi
Takahiro Higuchi
Takahiro Higuchi
Takahiro Higuchi
Satoshi Akagi
Masashi Yoshida
Toru Miyoshi
Hiroshi Ito
Kazufumi Nakamura
author_facet Yukihiro Saito
Naoko Nose
Toshihiro Iida
Kaoru Akazawa
Takayuki Kanno
Yuki Fujimoto
Takanori Sasaki
Masaru Akehi
Takahiro Higuchi
Takahiro Higuchi
Takahiro Higuchi
Satoshi Akagi
Masashi Yoshida
Toru Miyoshi
Hiroshi Ito
Kazufumi Nakamura
author_sort Yukihiro Saito
collection DOAJ
description IntroductionTransplantation of human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) is a promising treatment for heart failure. Information on long-term cell engraftment after transplantation is clinically important. However, clinically applicable evaluation methods have not yet been established.MethodsIn this study, to noninvasively assess transplanted cell engraftment, human SLC5A5, which encodes a sodium/iodide symporter (NIS) that transports radioactive tracers such as 125I, 18F-tetrafluoroborate (TFB), and 99mTc-pertechnetate (99mTcO4−), was transduced into human induced pluripotent stem cells (iPSCs), and nuclear medicine imaging was used to track engrafted human iPSC-CMs.ResultsTo evaluate the pluripotency of NIS-expressing human iPSCs, they were subcutaneously transplanted into immunodeficient rats. Teratomas were detected by 99mTcO4− single photon emission computed tomography (SPECT/CT) imaging. NIS expression and the uptake ability of 125I were maintained in purified human iPSC-CMs. NIS-expressing human iPSC-CMs transplanted into immunodeficient rats could be detected over time using 99mTcO4− SPECT/CT imaging. Unexpectedly, NIS expression affected cell proliferation of human iPSCs and iPSC-derived cells.DiscussionSuch functionally designed iPSC-CMs have potential clinical applications as a noninvasive method of grafted cell evaluation, but further studies are needed to determine the effects of NIS transduction on cellular characteristics and functions.
first_indexed 2024-03-12T02:02:06Z
format Article
id doaj.art-4b50470f16fc41e0995e29db4a77eded
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-03-12T02:02:06Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-4b50470f16fc41e0995e29db4a77eded2023-09-07T11:11:56ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-09-011010.3389/fcvm.2023.12613301261330In vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imagingYukihiro Saito0Naoko Nose1Toshihiro Iida2Kaoru Akazawa3Takayuki Kanno4Yuki Fujimoto5Takanori Sasaki6Masaru Akehi7Takahiro Higuchi8Takahiro Higuchi9Takahiro Higuchi10Satoshi Akagi11Masashi Yoshida12Toru Miyoshi13Hiroshi Ito14Kazufumi Nakamura15Department of Cardiovascular Medicine, Okayama University Hospital, Okayama, JapanMolecular Imaging Project of RECTOR Program, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, JapanDepartment of Cardiovascular Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, JapanDepartment of Cardiovascular Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, JapanMolecular Imaging Project of RECTOR Program, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, JapanMolecular Imaging Project of RECTOR Program, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, JapanOkayama Medical Innovation Center, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, JapanOkayama Medical Innovation Center, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, JapanMolecular Imaging Project of RECTOR Program, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, JapanDepartment of Nuclear Medicine, University Hospital Würzburg, Würzburg, GermanyComprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, GermanyDepartment of Cardiovascular Medicine, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, JapanDepartment of Chronic Kidney Disease and Cardiovascular Disease, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, JapanDepartment of Cardiovascular Medicine, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, JapanDepartment of General Internal Medicine 3, Kawasaki Medical School, Okayama, JapanDepartment of Cardiovascular Medicine, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, JapanIntroductionTransplantation of human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) is a promising treatment for heart failure. Information on long-term cell engraftment after transplantation is clinically important. However, clinically applicable evaluation methods have not yet been established.MethodsIn this study, to noninvasively assess transplanted cell engraftment, human SLC5A5, which encodes a sodium/iodide symporter (NIS) that transports radioactive tracers such as 125I, 18F-tetrafluoroborate (TFB), and 99mTc-pertechnetate (99mTcO4−), was transduced into human induced pluripotent stem cells (iPSCs), and nuclear medicine imaging was used to track engrafted human iPSC-CMs.ResultsTo evaluate the pluripotency of NIS-expressing human iPSCs, they were subcutaneously transplanted into immunodeficient rats. Teratomas were detected by 99mTcO4− single photon emission computed tomography (SPECT/CT) imaging. NIS expression and the uptake ability of 125I were maintained in purified human iPSC-CMs. NIS-expressing human iPSC-CMs transplanted into immunodeficient rats could be detected over time using 99mTcO4− SPECT/CT imaging. Unexpectedly, NIS expression affected cell proliferation of human iPSCs and iPSC-derived cells.DiscussionSuch functionally designed iPSC-CMs have potential clinical applications as a noninvasive method of grafted cell evaluation, but further studies are needed to determine the effects of NIS transduction on cellular characteristics and functions.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1261330/fullsodium/iodide symporterhuman induced pluripotent stem cell-derived cardiomyocytessingle photon emission computed tomographycell-based therapyin vivo imaging
spellingShingle Yukihiro Saito
Naoko Nose
Toshihiro Iida
Kaoru Akazawa
Takayuki Kanno
Yuki Fujimoto
Takanori Sasaki
Masaru Akehi
Takahiro Higuchi
Takahiro Higuchi
Takahiro Higuchi
Satoshi Akagi
Masashi Yoshida
Toru Miyoshi
Hiroshi Ito
Kazufumi Nakamura
In vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imaging
Frontiers in Cardiovascular Medicine
sodium/iodide symporter
human induced pluripotent stem cell-derived cardiomyocytes
single photon emission computed tomography
cell-based therapy
in vivo imaging
title In vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imaging
title_full In vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imaging
title_fullStr In vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imaging
title_full_unstemmed In vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imaging
title_short In vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imaging
title_sort in vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imaging
topic sodium/iodide symporter
human induced pluripotent stem cell-derived cardiomyocytes
single photon emission computed tomography
cell-based therapy
in vivo imaging
url https://www.frontiersin.org/articles/10.3389/fcvm.2023.1261330/full
work_keys_str_mv AT yukihirosaito invivotrackingtransplantedcardiomyocytesderivedfromhumaninducedpluripotentstemcellsusingnuclearmedicineimaging
AT naokonose invivotrackingtransplantedcardiomyocytesderivedfromhumaninducedpluripotentstemcellsusingnuclearmedicineimaging
AT toshihiroiida invivotrackingtransplantedcardiomyocytesderivedfromhumaninducedpluripotentstemcellsusingnuclearmedicineimaging
AT kaoruakazawa invivotrackingtransplantedcardiomyocytesderivedfromhumaninducedpluripotentstemcellsusingnuclearmedicineimaging
AT takayukikanno invivotrackingtransplantedcardiomyocytesderivedfromhumaninducedpluripotentstemcellsusingnuclearmedicineimaging
AT yukifujimoto invivotrackingtransplantedcardiomyocytesderivedfromhumaninducedpluripotentstemcellsusingnuclearmedicineimaging
AT takanorisasaki invivotrackingtransplantedcardiomyocytesderivedfromhumaninducedpluripotentstemcellsusingnuclearmedicineimaging
AT masaruakehi invivotrackingtransplantedcardiomyocytesderivedfromhumaninducedpluripotentstemcellsusingnuclearmedicineimaging
AT takahirohiguchi invivotrackingtransplantedcardiomyocytesderivedfromhumaninducedpluripotentstemcellsusingnuclearmedicineimaging
AT takahirohiguchi invivotrackingtransplantedcardiomyocytesderivedfromhumaninducedpluripotentstemcellsusingnuclearmedicineimaging
AT takahirohiguchi invivotrackingtransplantedcardiomyocytesderivedfromhumaninducedpluripotentstemcellsusingnuclearmedicineimaging
AT satoshiakagi invivotrackingtransplantedcardiomyocytesderivedfromhumaninducedpluripotentstemcellsusingnuclearmedicineimaging
AT masashiyoshida invivotrackingtransplantedcardiomyocytesderivedfromhumaninducedpluripotentstemcellsusingnuclearmedicineimaging
AT torumiyoshi invivotrackingtransplantedcardiomyocytesderivedfromhumaninducedpluripotentstemcellsusingnuclearmedicineimaging
AT hiroshiito invivotrackingtransplantedcardiomyocytesderivedfromhumaninducedpluripotentstemcellsusingnuclearmedicineimaging
AT kazufuminakamura invivotrackingtransplantedcardiomyocytesderivedfromhumaninducedpluripotentstemcellsusingnuclearmedicineimaging